To understand the interaction mechanism between graphene oxide (GO) and typical phytopathogens, a particular investigation was conducted about the antimicrobial activity of GO against two bacterial pathogens (P. syringae and X. campestris pv. undulosa) and two fungal pathogens (F. graminearum and F. oxysporum). The results showed that GO had a powerful effect on the reproduction of all four pathogens (killed nearly 90% of the bacteria and repressed 80% macroconidia germination along with partial cell swelling and lysis at 500 μg mL(-1)). A mutual mechanism is proposed in this work that GO intertwinds the bacteria and fungal spores with a wide range of aggregated graphene oxide sheets, resulting in the local perturbation of their cell membrane and inducing the decrease of the bacterial membrane potential and the leakage of electrolytes of fungal spores. It is likely that GO interacts with the pathogens by mechanically wrapping and locally damaging the cell membrane and finally causing cell lysis, which may be one of the major toxicity actions of GO against phytopathogens. The antibacterial mode proposed in this study suggests that the GO may possess antibacterial activity against more multi-resistant bacterial and fungal phytopathogens, and provides useful information about the application of GO in resisting crop diseases.

Graphene oxide and its derivatives have been widely explored for their antimicrobial properties due to their high surface-to-volume ratios and unique chemical and physical properties. However, little information is available on their effects on viruses. In this study, we report the broad-spectrum antiviral activity of GO against pseudorabies virus (PRV, a DNA virus) and porcine epidemic diarrhea virus (PEDV, an RNA virus). Our results showed that GO significantly suppressed the infection of PRV and PEDV for a 2 log reduction in virus titers at noncytotoxic concentrations. The potent antiviral activity of both GO and rGO can be attributed to the unique single-layer structure and negative charge. First, GO exhibited potent antiviral activity when conjugated with PVP, a nonionic polymer, but not when conjugated with PDDA, a cationic polymer. Additionally, the precursors Gt and GtO showed much weaker antiviral activity than monolayer GO and rGO, suggesting that the nanosheet structure is important for antiviral properties. Furthermore, GO inactivated both viruses by structural destruction prior to viral entry. The overall results suggest the potential of graphene oxide as a novel promising antiviral agent with a broad and potent antiviral activity.

No abstract

Prompt recombination of photogenerated electrons and holes in bulk and on the surface of photocatalysts harshly impedes the photocatalytic efficiency. However, the simultaneous manipulation of photocharges in the two locations is challenging. Herein, the synchronous promotion of bulk and surface separation of photoinduced charges for prominent CO2 photoreduction by coupling macroscopic spontaneous polarization and surface oxygen vacancies (OVs) of BiOIO3 single crystals is reported. The oriented growth of BiOIO3 single‐crystal nanostrips along the [001] direction, ensuing substantial well‐aligned IO3 polar units, renders a large enhancement for the macroscopic polarization electric field, which is capable of driving the rapid separation and migration of charges from bulk to surface. Meanwhile the introduction of surface OVs establishes a local electric field for charge migration to catalytic sites on the surface of BiOIO3 nanostrips. Highly polarized BiOIO3 nanostrips with ample OVs demonstrate outstanding CO2 reduction activity for CO production with a rate of 17.33 µmol g−1 h−1 (approximately ten times enhancement) without any sacrificial agents or cocatalysts, being one of the best CO2 reduction photocatalysts in the gas–solid system reported so far. This work provides an integrated solution to governing charge movement behavior on the basis of collaborative polarization from bulk and surface.

Visible‐light‐driven CO2 reduction to valuable chemicals without sacrificial agents and cocatalysts remains challenging, especially for metal‐free photocatalytic systems. Herein, a novel donor–acceptor (D–A) covalent organic framework (CT‐COF) was constructed by the Schiff‐base reaction of carbazole‐triazine based D–A monomers and possessed a suitable energy band structure, strong visible‐light‐harvesting, and abundant nitrogen sites. CT‐COF as a metal‐free photocatalyst could reduce CO2 with gaseous H2O to CO as the main carbonaceous product with approximately stoichiometric O2 evolution under visible‐light irradiation and without cocatalyst. The CO evolution rate (102.7 μmol g−1 h−1) was 68.5 times that of g‐C3N4 under the same conditions. In situ Fourier‐transform (FT)IR analysis indicated that CT‐COF could adsorb and activate the CO2 and H2O molecules and that COOH* species may be a key intermediate. DFT calculations suggested that nitrogen atoms in the triazine rings may be photocatalytically active sites.

Development of novel antiviral reagents is of great importance for the control of virus spread. Here, AgS nanoclusters (NCs) were proved for the first time to possess highly efficient antiviral activity by using porcine epidemic diarrhea virus (PEDV) as a model of coronavirus. Analyses of virus titers showed that AgS NCs significantly suppressed the infection of PEDV by about 3 orders of magnitude at the noncytotoxic concentration at 12 h postinfection, which was further confirmed by the expression of viral proteins. Mechanism investigations indicated that AgS NCs treatment inhibits the synthesis of viral negative-strand RNA and viral budding. AgS NCs treatment was also found to positively regulate the generation of IFN-stimulating genes (ISGs) and the expression of proinflammation cytokines, which might prevent PEDV infection. This study suggest the novel underlying of AgS NCs as a promising therapeutic drug for coronavirus.

Oxygen vacancies induced exciton dissociation of flexible BiOCl nanosheets for effective photocatalytic CO2 conversion via the CO2 hydrogenation pathway.

No abstract